EICVX | RMFCX | EICVX / RMFCX | |
Total Expense Ratio | 1.21 | 0.91 | 133% |
Annual Report Gross Expense Ratio | 1.25 | 0.91 | 137% |
Fund Existence | 14 years | 23 years | - |
Gain YTD | 10.761 | 9.836 | 109% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 341M | 109B | 0% |
Annual Yield % from dividends | 1.84 | 1.27 | 145% |
Returns for 1 year | 11.05 | 10.49 | 105% |
Returns for 3 years | 27.38 | 30.44 | 90% |
Returns for 5 years | 68.85 | 62.06 | 111% |
Returns for 10 years | 56.70 | 77.35 | 73% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSLIX | 16.70 | N/A | N/A |
Goldman Sachs Large Cap Value Instl | |||
PMFMX | 23.11 | N/A | N/A |
Principal MidCap S&P 400 Index R3 | |||
VTSNX | 148.36 | N/A | N/A |
Vanguard Total Intl Stock Index I | |||
JFNCX | 54.93 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
CBGAX | 14.28 | N/A | N/A |
ClearBridge Global Infrastructure Inc C |